Cord blood: A promising source of allogeneic natural killer cells for immunotherapy

Cytotherapy

Volumn 17, Issue 1, 2015, Pages 1-2

  Shaim, Hila ^a   Yvon, Eric ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; STAT3 PROTEIN; CYTOKINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADVANCED CANCER; ALLOGENEIC NATURAL KILLER CELL; BLOOD; CELL EXPANSION; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOTHERAPY; K562 CELL LINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOLID TUMOR; TELOMERE; TUMOR ASSOCIATED LEUKOCYTE; UMBILICAL CORD BLOOD; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; IMMUNOLOGY;

CYTOKINES; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL;

EID: 84927169244     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.12.001     Document Type: Note

References (9)

1. Alnabhan R., Madrigal A., Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy 2015, 17:73-85.
2. Verneris M.R., Miller J.S. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Br J Haematol 2009, 147:185-191.
3. Pillet A.H., Bugault F., Theze J., Chakrabarti L.A., Rose T. Aprogrammed switch from IL-15- to IL-2-dependent activation in human NK cells. JImmunol 2009, 182:6267-6277.
4. Bjorkstrom N.K., Riese P., Heuts F., Andersson S., Fauriat C., Ivarsson M.A., et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-3864.
5. Skak K., Frederiksen K.S., Lundsgaard D. Interleukin-21 activates human natural killer cells and modulates their surface receptor expression. Immunology 2008, 123:575-583.
6. Denman C.J., Senyukov V.V., Somanchi S.S., Phatarpekar P.V., Kopp L.M., Johnson J.L., et al. Membrane-bound IL-21 promotes sustained exvivo proliferation of human natural killer cells. PLos One 2012, 7:e30264.
7. Somanchi S.S., Senyukov V.V., Denman C.J., Lee D.A. Expansion, purification, and functional assessment of human peripheral blood NK cells. JVis Exp 2011, 2:2540.
8. Fujisaki H., Kakuda H., Shimasaki N., Imai C., Ma J., Lockey T., et al. Expansion of highly cytotoxic human natural killer cells from cancer cell therapy. Cancer Res 2009, 69:4010-4017.
9. Bachanova V., Cooley S., Defor T.E., Verneris M.R., Zhang B., McKenna D.H., et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood 2014, 123:3855-3863.